Breast protein called cyclin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Breast Cell Line, Tumor Tumor Cells, Cultured Mammary Glands, Human MCF-7 Cells Milk, Human Cell Line Nipples Cell Nucleus Axilla Epithelial Cells HeLa Cells Cells, Cultured Mammary Glands, Animal 3T3 Cells Fibroblasts Lymph Nodes NIH 3T3 Cells Cytoplasm

Organisms3

Mice, Nude Starfish Mice, Transgenic

Diseases30

Carcinoma, Ductal, Breast Breast Diseases Breast Neoplasms, Male Fibrocystic Breast Disease Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Carcinoma, Lobular Neoplasm Metastasis Lymphatic Metastasis Carcinoma Mammary Neoplasms, Experimental Breast Cyst Fibroadenoma Neoplasms, Hormone-Dependent Cell Transformation, Neoplastic Carcinoma, Ductal Carcinoma in Situ Neoplasm Recurrence, Local Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Genetic Predisposition to Disease Disease Progression Neoplasms Ovarian Neoplasms Adenocarcinoma Bone Neoplasms Hyperplasia Lung Neoplasms Adenofibroma Breast Neoplasms

Chemicals and Drugs96

Cyclin D1 Cyclin A Cyclin E Cyclin B Cyclin B1 Cyclin D2 Cyclin D3 Cyclin A1 Cyclin A2 Cyclin D Cyclin G1 Cyclins Cyclin G Cyclin C Cyclin-Dependent Kinases Cyclin B2 Cyclin T Cyclin-Dependent Kinase 2 Cyclin G2 Cyclin H Cyclin-Dependent Kinase 4 Receptors, Estrogen CDC2-CDC28 Kinases CDC2 Protein Kinase Cell Cycle Proteins Receptor, erbB-2 Cyclin-Dependent Kinase Inhibitor p27 Receptors, Progesterone Retinoblastoma Protein Tamoxifen Tumor Markers, Biological Cyclin I Protein-Serine-Threonine Kinases Oncogene Proteins RNA, Messenger Neoplasm Proteins Cyclin-Dependent Kinase Inhibitor p21 Tumor Suppressor Proteins Cyclin-Dependent Kinase 6 Antineoplastic Agents Antineoplastic Agents, Hormonal Estrogen Receptor alpha Estrogens Transcription Factors Tumor Suppressor Protein p53 Proto-Oncogene Proteins Ki-67 Antigen RNA, Small Interfering BRCA1 Protein DNA-Binding Proteins Estrogen Antagonists BRCA2 Protein Nuclear Proteins Estradiol E2F Transcription Factors Microtubule-Associated Proteins Aromatase Inhibitors Proliferating Cell Nuclear Antigen cdc25 Phosphatases DNA, Neoplasm F-Box Proteins Cyclin-Dependent Kinase Inhibitor p16 Enzyme Inhibitors Protamine Kinase DNA Primers Nitriles Maturation-Promoting Factor E2F1 Transcription Factor Proto-Oncogene Proteins c-myc Protein Kinases RNA, Neoplasm Recombinant Fusion Proteins Transcription Factor DP1 Carrier Proteins Cyclin-Dependent Kinase 9 Selective Estrogen Receptor Modulators Retinoblastoma-Binding Protein 1 Cyclophosphamide Retinoblastoma-Like Protein p107 Antibodies, Monoclonal beta Catenin S-Phase Kinase-Associated Proteins Antineoplastic Agents, Phytogenic Proto-Oncogene Proteins c-akt Epirubicin Ubiquitin-Protein Ligase Complexes Antibodies, Monoclonal, Humanized Taxoids Proteasome Endopeptidase Complex Fluorouracil Cyclin-Dependent Kinase Inhibitor Proteins CDC28 Protein Kinase, S cerevisiae Trans-Activators Receptor, Epidermal Growth Factor DNA Mucin-1

Analytical, Diagnostic and Therapeutic Techniques and Equipment57

Mammography Breast Implants Breast Self-Examination Immunohistochemistry Prognosis Mastectomy Ultrasonography, Mammary Neoplasm Staging Blotting, Western Case-Control Studies Risk Factors Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Transfection Mastectomy, Segmental Mammaplasty Chemotherapy, Adjuvant Gene Expression Profiling Breast Implantation Survival Analysis Disease-Free Survival Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Immunoenzyme Techniques Cohort Studies Mass Screening Incidence Biopsy, Needle Oligonucleotide Array Sequence Analysis Survival Rate Risk Retrospective Studies Tissue Array Analysis Models, Biological Sensitivity and Specificity Prospective Studies Risk Assessment Polymerase Chain Reaction Immunoblotting Xenograft Model Antitumor Assays Mastectomy, Modified Radical Transplantation, Heterologous Multivariate Analysis In Situ Hybridization, Fluorescence Proportional Hazards Models Neoadjuvant Therapy Odds Ratio Neoplasm Transplantation Reproducibility of Results Predictive Value of Tests Gene Knockdown Techniques Precipitin Tests Biopsy Immunoprecipitation Tumor Burden Radiotherapy, Adjuvant

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes49

Breast Feeding Cell Cycle G1 Phase Gene Expression Regulation, Neoplastic S Phase Cell Proliferation Cell Division Phosphorylation Mitosis Genes, bcl-1 Signal Transduction Genes, BRCA1 Apoptosis Time Factors G2 Phase Postmenopause Down-Regulation Transfection Promoter Regions, Genetic Mutation Premenopause Base Sequence Genes, erbB-2 Drug Resistance, Neoplasm Protein Binding Transcription, Genetic Menopause Genes, BRCA2 Gene Expression Genetic Predisposition to Disease Up-Regulation Amino Acid Sequence G0 Phase Gene Amplification Gene Expression Regulation RNA Interference Enzyme Activation Risk Sensitivity and Specificity Cell Growth Processes Cell Movement Phenotype Odds Ratio Dose-Response Relationship, Drug Transcriptional Activation Germ-Line Mutation Genes, Tumor Suppressor Cell Cycle Checkpoints Gene Silencing

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Information Science5

Molecular Sequence Data Base Sequence Amino Acid Sequence Incidence Survival Rate

Named Groups1

Health Care21

Case-Control Studies Risk Factors Survival Analysis Disease-Free Survival Follow-Up Studies Treatment Outcome Cohort Studies Mass Screening Incidence Survival Rate Risk Retrospective Studies Age Factors Sensitivity and Specificity Prospective Studies Risk Assessment Multivariate Analysis Proportional Hazards Models Odds Ratio Reproducibility of Results Predictive Value of Tests

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Cyclin D1 Cyclin A Breast Cyclin E Cyclin B Cyclin B1 Cyclin D2 Cyclin D3 Cyclin A1 Cyclin A2 Cyclin D Carcinoma, Ductal, Breast Breast Diseases Cyclin G1 Cyclins Cyclin G Cyclin C Cyclin-Dependent Kinases Cyclin B2 Breast Feeding Cyclin T Cyclin-Dependent Kinase 2 Cell Cycle Cyclin G2 Cyclin H Cell Line, Tumor Cyclin-Dependent Kinase 4 Receptors, Estrogen CDC2-CDC28 Kinases Breast Neoplasms, Male G1 Phase CDC2 Protein Kinase Mammography Gene Expression Regulation, Neoplastic Cell Cycle Proteins Fibrocystic Breast Disease Receptor, erbB-2 Cyclin-Dependent Kinase Inhibitor p27 S Phase Breast Implants Receptors, Progesterone Retinoblastoma Protein Cell Proliferation Tamoxifen Breast Self-Examination Tumor Cells, Cultured Immunohistochemistry Tumor Markers, Biological Cyclin I Prognosis Cell Division Phosphorylation Protein-Serine-Threonine Kinases Oncogene Proteins Carcinoma, Intraductal, Noninfiltrating Mitosis Neoplasm Invasiveness RNA, Messenger Mastectomy Genes, bcl-1 Carcinoma, Lobular Neoplasm Proteins Cyclin-Dependent Kinase Inhibitor p21 Neoplasm Metastasis Tumor Suppressor Proteins Ultrasonography, Mammary Cyclin-Dependent Kinase 6 Antineoplastic Agents Neoplasm Staging Antineoplastic Agents, Hormonal Signal Transduction Genes, BRCA1 Lymphatic Metastasis Blotting, Western Apoptosis Case-Control Studies Risk Factors Carcinoma Time Factors Estrogen Receptor alpha G2 Phase Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Postmenopause Mammary Glands, Human MCF-7 Cells Estrogens Down-Regulation Molecular Sequence Data Transfection Promoter Regions, Genetic Mastectomy, Segmental Milk, Human Mammaplasty Transcription Factors Breast Cyst Mutation Tumor Suppressor Protein p53 Proto-Oncogene Proteins Mice, Nude

No FAQ available that match "breast protein called cyclin"